查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1514325

吸收性抗菌包膜市场：现况分析与预测（2024-2032）

Absorbable Antibacterial Envelope Market: Current Analysis and Forecast (2024-2032)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 120 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

吸收性抗菌包膜市场预计将呈现约 5% 的成长率。这主要是由于心血管疾病治疗研究和开发的不断改进正在推动市场需求。例如，2022 年4 月，Aziyo Biologics, Inc. 的CanGaroo RM 抗菌包膜获得了美国食品和药物管理局(FDA) 的510(k) 上市前批准，这是一种用于植入式电子设备( IED) 的下一代生物材料包膜。Aziyo Biologics 是一家商业阶段的再生医学公司，致力于透过开发独特的产品来改善手术患者的治疗效果，包括：

依类型划分，市场分为心臟再同步治疗去颤器 (CRT-D) 和植入式心律转復除颤器 (ICD)。心臟再同步治疗去颤器 (CRT-D) 类别预计将占据可吸收抗菌包膜市场的最大市场占有率，解决日益增长的设备相关感染问题。由于 CRT-D 用于患有严重心臟衰竭的患者，因此它们比 ICD 或标准起搏器更复杂且植入时间更长，并且需要采取特殊措施以避免感染。关于可吸收的抗菌包膜，这是为了降低装置植入部位周围可能的感染风险。CRT-D 设备的病人安全性的提高和效率的提高将促使这些设备的使用增加，从而增加对可吸收抗菌敷料的需求。这就是为什么心臟设备和感染控制解决方案的需求相结合对于推动该领域的发展至关重要。

根据最终用户，市场分为医院、门诊手术中心（ASC）等。其中，到 2023 年，医院的价值将领先全球市场。这主要是因为医院制定了患者护理标准，并鼓励使用可吸收的抗菌敷料来预防心臟装置植入物的感染。此外，医院中植牙手术的数量不断增加，以及对这些手术中更好的标准和品质的日益关注，进一步提高了这些信封的利用率。促进市场成长的另一个关键因素是医院网路和集团采购组织采用标准化程序，在其附属组织中使用供应商提供的吸收性抗菌敷料，实现规模经济并扩大市场饱和度。

为了更瞭解吸收性抗菌信封的市场介绍，市场分为北美（美国、加拿大、北美其他地区）、欧洲（德国、英国、法国、西班牙、义大利、欧洲其他地区）、亚太地区（中国） 、日本）、印度、亚太地区其他地区）和世界其他地区。特别是，由于心血管疾病的高盛行率和心臟装置植入物数量的增加，北美可吸收的抗菌包膜市场预计将显着增长。该地区先进的医疗保健基础设施，加上强有力的监管支持和高额医疗保健支出，正在推动可吸收抗菌绷带等创新医疗解决方案的采用。此外，主要市场参与者的存在和持续的研发活动也有助于市场扩张。人们对医疗程序中感染预防重要性的认识不断提高以及先进医疗技术的采用也推动了北美市场的发展。

目录

第1章 市场介绍

  • 市场定义
  • 主要目标
  • 利益相关者
  • 限制

第2章 研究方法或前提条件

  • 调查过程
  • 调查方法
  • 受访者简介

第3章 执行摘要

  • 业界总结
  • 分部展望
    • 市场成长的力量
  • 区域展望

第四章市场动态

  • 促进因素
  • 机会
  • 抑制因素
  • 趋势
  • PESTEL 分析
  • 需求面分析
  • 供给侧分析
    • 併购
    • 产品上市及投资场景
    • 产业洞察：主要新创公司及其独特策略

第5章 价格分析

  • 区域价格分析
  • 影响价格的因素

第六章全球吸收性抗菌信封市场收入，2022-2032

第七章 市场考量：依类型

  • 心臟再同步治疗去颤器 (CRT-D)
  • 植入式心臟復律去颤器 (ICD)

第 8 章市场分析：依最终用户

  • 医院
  • 门诊手术中心 (ASC)
  • 其他

第9章市场分析：依地区

  • 北美
    • 美国
    • 加拿大
    • 其他北美
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 亚太其他地区
  • 其他地区

第10章价值链分析

  • 边际分析
  • 进入市场的企业名单

第十一章竞争格局

  • 比赛仪表板
  • 竞争市场定位分析
  • 波特五力分析

第12章 公司简介

  • Medtronic
    • Company Overview
    • Key Financials
    • SWOT Analysis
    • Product Portfolio
    • Recent Developments
  • Elutia

第13章 缩写与先决条件

第14章 附录

简介目录
Product Code: UMHE212870

The absorbable antibacterial envelope market concerns the manufacture and use of distinct, biodegradable pouches for containment of cardiovascular and other implantable devices, like pacemakers and defibrillators, which release antimicrobial substances to protect against infection. This market is influenced by several factors, such as a rising rate of cardiac ailments, innovations in biomedical equipment, and a heightened concern over hospital-acquired illnesses. For instance, it is estimated that a heart attack happens within every 40 seconds in the United States and each year, 805,000 people in the United States suffer a heart attack based on the CDC report updated in October 2022. An increasing incidence and implantation of cardiac devices, along with the need for new and effective anti-infective strategies in device use, offers market promotion. Also, the availability of favorable government policies, a rise in healthcare expenditure, and the use of advanced medical solutions in developing countries help to drive the solid growth of the market.

The market for absorbable antibacterial envelope market is set to exhibit a growth rate of about 5%. This is mainly due to the continuous improvements in research and development in the treatment of cardiovascular diseases driving the demand of the market. For instance, in April 2022, Aziyo Biologics, Inc. filed a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for CanGaroo RM antibacterial envelope, its next-generation biomaterial envelope for use with implantable electronic devices (IED). Aziyo Biologics is a commercial-stage regenerative medicine firm dedicated to developing the following line of distinctive products and enhancing surgical patient outcomes.

Based on type, the market is segmented into cardiac resynchronization therapy defibrillators (CRT-D) and implantable cardioverter defibrillators (ICD). The cardiac resynchronization therapy defibrillators (CRT-D) category is expected to have the largest market share of the absorbable antibacterial envelope market by addressing the rising concerns of device-related infections. CRT-D devices are used for patients with severe heart failure and hence, need some extra measures to avoid infections because of their complexity and longer implantation times than required for ICDs or standard pacemakers. As for the absorbable antibacterial envelopes, it is to reduce infection risks that may be around the area of implantation of the device. Improved patient safety and increased efficiency of the CRT-D devices lead to increased usage of these devices, hence the demand for absorbable antibacterial envelopes. That is the reason why the combination of cardiac devices with the need for infection control solutions is crucial in developmental progression within this sector.

Based on end-user, the market has been divided into hospitals, ambulatory surgical centers (ASCs), and others. Among them, the hospitals were leading the global market in terms of value in 2023. This is mainly because hospitals set standards for patient care, encouraging the use of absorbable antibacterial envelopes to prevent infections in cardiac device implantations. Furthermore, the increasing number of implant surgeries in hospitals, integrated with an increased focus on better standards and quality in these procedures, further the usage rate of these envelopes. Another important factor that contributes to the market growth is the role of hospital networks or group purchasing organizations as they adopt standardized procedures of using absorbable antibacterial envelopes provided by the vendors across their affiliated organizations, achieving economies of scale, and expanding the market saturation.

For a better understanding of the market adoption of absorbable antibacterial envelope, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. Among them, the North American absorbable antibacterial envelope market is poised for significant growth, driven by the high prevalence of cardiovascular diseases and the increasing number of cardiac device implantations. The region's advanced healthcare infrastructure, coupled with strong regulatory support and substantial healthcare spending, facilitates the adoption of innovative medical solutions like absorbable antibacterial envelopes. Additionally, the presence of major market players and ongoing research and development activities further contribute to market expansion. Rising awareness about the importance of infection prevention in medical procedures and the adoption of advanced healthcare technologies also propel the market forward in North America.

Some of the major players operating in the market include Medtronic and Elutia.

TABLE OF CONTENTS

1.MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2.RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Global Absorbable Antibacterial Envelope Market
  • 2.2. Research Methodology of the Global Absorbable Antibacterial Envelope Market
  • 2.3. Respondent Profile

3.EXECUTIVE SUMMARY

  • 3.1. Industry Synopsis
  • 3.2. Segmental Outlook
    • 3.2.1. Market Growth Intensity
  • 3.3. Regional Outlook

4.MARKET DYNAMICS

  • 4.1. Drivers
  • 4.2. Opportunity
  • 4.3. Restraints
  • 4.4. Trends
  • 4.5. PESTEL Analysis
  • 4.6. Demand Side Analysis
  • 4.7. Supply Side Analysis
    • 4.7.1. Merger & Acquisition
    • 4.7.2. Product Launch and Investment Scenario
    • 4.7.3. Industry Insights: Leading Startups and Their Unique Strategies

5.PRICING ANALYSIS

  • 5.1. Regional Pricing Analysis
  • 5.2. Price Influencing Factors

6.GLOBAL ABSORBABLE ANTIBACTERIAL ENVELOPE MARKET REVENUE (USD MN), 2022-2032F

7.MARKET INSIGHTS BY TYPE

  • 7.1. Cardiac Resynchronization Therapy Defibrillators (CRT-D)
  • 7.2. Implantable Cardioverter Defibrillators (ICD)

8.MARKET INSIGHTS BY END-USER

  • 8.1. Hospitals
  • 8.2. Ambulatory Surgical Centers (ASCs)
  • 8.3. Others

9.MARKET INSIGHTS BY REGION

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. U.K.
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Rest of Asia-Pacific
  • 9.4. Rest of World

10.VALUE CHAIN ANALYSIS

  • 10.1. Marginal Analysis
  • 10.2. List of Market Participants

11.COMPETITIVE LANDSCAPE

  • 11.1. Competition Dashboard
  • 11.2. Competitor Market Positioning Analysis
  • 11.3. Porter Five Forces Analysis

12.COMPANY PROFILED

  • 12.1. Medtronic
    • 12.1.1. Company Overview
    • 12.1.2. Key Financials
    • 12.1.3. SWOT Analysis
    • 12.1.4. Product Portfolio
    • 12.1.5. Recent Developments
  • 12.2. Elutia

13.ACRONYMS & ASSUMPTION

14.ANNEXURE